Phase II trial of intravenous human dental pulp stem cell therapy for Huntington's disease: a randomized, double-blind, placebo-controlled study.

Saved in:
Bibliographic Details
Title: Phase II trial of intravenous human dental pulp stem cell therapy for Huntington's disease: a randomized, double-blind, placebo-controlled study.
Authors: Fernandes, Joyce Macedo Sanches1,2 (AUTHOR) joycemacedosilva@gmail.com, Pagani, Eduardo2,3 (AUTHOR) eduardo.pagani@azdcro.com.br, Wenceslau, Cristiane Valverde3 (AUTHOR) cristiane.valverde@cellavitabrasil.com.br, Ynoue, Leandro Hideki2 (AUTHOR) leandro.ynoue@azdcro.com.br, Ferrara, Luciana2 (AUTHOR) luciana.ferrara@azdcro.com.br, Kerkis, Irina4 (AUTHOR) irina.kerkis@butantan.gov.br
Source: Stem Cell Research & Therapy. 8/6/2025, Vol. 16 Issue 1, p1-13. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17576512
DOI:10.1186/s13287-025-04557-2